Risk of Gvhd and Survival in Patients with Acute Leukemia Who Were Bridged to Allogeneic Stem Cell Transplantation (alloSCT) with Venetoclax- Based Therapy

Akash Mukherjee,Denái R. Milton,Elias Jabbour,Naval Daver,Alison Gulbis,Celina Ledesma,Marina Konopleva,Courtney D. DiNardo,Farhad Ravandi,Tapan M. Kadia,Gheath Alatrash,Amin M. Alousi,May Daher, David Marin,Amanda L. Olson,Betul Oran,Partow Kebriaei,Neeraj Saini,Samer A. Srour,Uday R. Popat

Blood（2020）

引用 0|浏览1

暂无评分

摘要

Background: Venetoclax has shown a promising benefit in patients (pts) with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). There is paucity of information about the efficacy and risk of GVHD with alloSCT post venetoclax -based therapy.

查看译文

关键词

allogeneic stem cell transplantation,acute leukemia,gvhd

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要